Egypt:GSK Egypt considers merge of Amoun Pharmaceutical Industries
- 28 December 2020 / News / 155 / Africa - Bi 3
The board of directors of Glaxo SmithKline (GSK Egypt) decided to form a committee to study the merge of Amoun Pharmaceutical Industries into the company.
The board also approved to refer the decision of the appointment of independent board members to the shareholders for approval, according to a bourse disclosure on Thursday.
Ashraf Mansour was named the company's Chairman, as a representative of Glaxo Group Ltd, and Henry Antaki was appointed as Managing Director, as a representative of Glaxo Group Ltd.
Earlier in December, the company denied news reports about the acquisition of its subsidiary Amoun Pharmaceutical Industries.
During the first nine months of 2020, GSK Egypt reported net profits of EGP 101.41 million, up from EGP 67.03 million in the corresponding period a year earlier
EGYPT:BUSINESS Egyptian Drug Authority adopts new measures to facilitate human drugs registration Egyptian Drug Authority adopts new measures to facilitate human drugs registration
- 18 December 2020
The Egyptian Drug Authority (EDA) has announced the development of new mechanisms to facilitate procedures for registering human drugs.EDA Spokesperson Ali Al-Ghamrawi said that it was decided to allo...
Egypt receives first batch of Chinese coronavirus vaccine, to provide it free for citizens
- 11 December 2020
Egypt has received on Thursday the first batches of the Chinese coronavirus vaccine at Cairo Airport later in the day, the Egyptian Ministry of Health said. Egypt’s Minister of Health Hala Z...